March 6, 20261 min
Medically reviewed: 3/6/2026 • Sources verified: 3/6/2026
Retatrutide For Obstructive Sleep Apnea Triumph Trial Results
Discover the latest retatrutide for obstructive sleep apnea TRIUMPH trial results. Explore Phase 3 status, efficacy data from related trials, safety profile including dysesthesia, and FDA approval timeline for this triple agonist.
Retatrutide shows strong potential for treating obstructive sleep apnea (OSA) by driving major weight loss, a key factor in managing this condition. In the ongoing TRIUMPH Phase 3 program, specific retatrutide for obstructive sleep apnea TRIUMPH trial results from trials
Ready to explore medical weight management?
Consult with US-based telehealth providers to discuss FDA-approved GLP-1 medications and personalized obesity treatment plans.